Updates in the Treatment of Leber Hereditary ...

In today's episode, host Dr. Ben Young welcomes 3 core members of the Academy's Advocacy team: Dr. John McAllister, Secretary for Federal Affairs; Dr. John Peters, Secretary for State Affairs; and Rebecca Hyder, Vice President of Government Affairs. The panel discusses why routin ...  Show more

Host Dr. Andrew Pouw welcomes Drs. Gustavo De Moraes, Aakriti Shukla, and Simon John to discuss their team's work spanning the full arc of nicotinamide as a neuroprotection candidate for glaucoma, from bench to clinical trials. For all episodes or to claim CME credit for selected ...  Show more

In this episode of Blood Cancer Talks, we have Dr. Adrian Minson from the Peter MacCallum Cancer Centre to discuss the latest developments in lymphoma presented at the recent EHA and ICML meetings in June 2025. The episode focuses primarily on the emerging role of bispecific anti ...  Show more

In this 254th episode I welcome Dr. Gillian Isaac back to the show for another ABA Keyword episode. We discuss muscular dystrophies and trisomy 21.Our Sponsors:* Check out BetterHelp: https://www.betterhelp.com* Check out FIGS and use my code FIGSRX for a great deal: https://wear ...  Show more

In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medication ...  Show more

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ...  Show more